Literature DB >> 2002642

Osmoregulation of thirst and vasopressin release in severe chronic renal failure.

N B Argent1, L M Burrell, T H Goodship, R Wilkinson, P H Baylis.   

Abstract

Subjects with severe chronic renal failure (CRF) have higher plasma concentrations of arginine vasopressin (AVP) than normal subjects, and some develop severe thirst. Eight patients with CRF and seven matched controls underwent hypertonic saline infusion to explore the relationship of thirst and plasma AVP with plasma osmolality. Differences in urea concentration between the two groups were controlled for by correcting measured osmolality to a urea of zero. Linear regression analysis of the relationships between plasma AVP and thirst with plasma osmolality (corrected for urea) was performed. Mean results were: control, pAVP = 0.26 (pOsmc - 283.7) versus CRF, pAVP = 0.72 (pOsmc - 282.0); and control, thirst = 4.0 (pOsmc - 279.4) versus CRF, thirst = 3.5 (pOsmc - 281.8). The apparent sensitivity (slope) of AVP release was greater in severe CRF than in normal controls (P = 0.04). There was no significant difference between the groups in thirst sensitivity, threshold for thirst onset and threshold for AVP release. Osmoregulated thirst was normal in severe CRF, but increasing osmolality leads to higher concentrations of AVP than would be expected.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002642     DOI: 10.1038/ki.1991.36

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

Review 1.  Hypertension in Pregnancy: Defining Blood Pressure Goals and the Value of Biomarkers for Preeclampsia.

Authors:  Pitchaphon Nissaisorakarn; Sairah Sharif; Belinda Jim
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

2.  Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent.

Authors:  Nicole K Littlejohn; Rick B Siel; Pimonrat Ketsawatsomkron; Christopher J Pelham; Nicole A Pearson; Aline M Hilzendeger; Beth A Buehrer; Benjamin J Weidemann; Huiping Li; Deborah R Davis; Anthony P Thompson; Xuebo Liu; Martin D Cassell; Curt D Sigmund; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-03-27       Impact factor: 3.619

Review 3.  Dysnatremias in patients with kidney disease.

Authors:  Sara Combs; Tomas Berl
Journal:  Am J Kidney Dis       Date:  2013-11-14       Impact factor: 8.860

4.  Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model.

Authors:  Mark K Santillan; Donna A Santillan; Sabrina M Scroggins; James Y Min; Jeremy A Sandgren; Nicole A Pearson; Kimberly K Leslie; Stephen K Hunter; Gideon K D Zamba; Katherine N Gibson-Corley; Justin L Grobe
Journal:  Hypertension       Date:  2014-07-07       Impact factor: 10.190

Review 5.  Vasopressin antagonists in polycystic kidney disease.

Authors:  Vicente E Torres
Journal:  Semin Nephrol       Date:  2008-05       Impact factor: 5.299

Review 6.  Quench the thirst: lessons from clinical thirst trials.

Authors:  Shoshana R Arai; Alice Butzlaff; Nancy A Stotts; Kathleen A Puntillo
Journal:  Biol Res Nurs       Date:  2013-10-16       Impact factor: 2.522

7.  Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment.

Authors:  Debbie Zittema; Niek F Casteleijn; Stephan J L Bakker; Lianne S M Boesten; A A Margreeth Duit; Casper F M Franssen; Carlo A J M Gaillard; Ron T Gansevoort
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

8.  Copeptin in Patients with Pregnancy-Induced Hypertension.

Authors:  Agnieszka Marek; Rafał Stojko; Agnieszka Drosdzol-Cop
Journal:  Int J Environ Res Public Health       Date:  2021-06-15       Impact factor: 3.390

9.  Serum copeptin levels in adolescents with primary hypertension.

Authors:  Edyta Tenderenda-Banasiuk; Anna Wasilewska; Renata Filonowicz; Urszula Jakubowska; Marlena Waszkiewicz-Stojda
Journal:  Pediatr Nephrol       Date:  2013-12-29       Impact factor: 3.714

Review 10.  The sensitivity of the human thirst response to changes in plasma osmolality: a systematic review.

Authors:  Fintan Hughes; Monty Mythen; Hugh Montgomery
Journal:  Perioper Med (Lond)       Date:  2018-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.